| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 1410880-22-6 | JNK-IN-8 |
≥98% | | 询价 |
| 2 | 129-56-6 | SP600125(SP600125 NSC75890) |
≥98% | | 询价 |
| 3 | 869886-67-9 | Ulixertinib(BVD-523 VRT752271) |
≥98% | | 询价 |
| 4 | 181223-80-3 | DEL-22379 |
≥98% | | 询价 |
| 5 | 896720-20-0 | VX-11e |
≥98% | | 询价 |
| 6 | 1435488-37-1 | XMD17-109 |
≥98% | | 询价 |
| 7 | 1453848-26-4 | Ravoxertinib(GDC-0994 RG-7842) |
≥98% | | 询价 |
| 8 | 865362-74-9 | FR 180204 |
≥98% | | 询价 |
| 9 | 1234480-50-2 | XMD8-92 |
≥98% | | 询价 |
| 10 | 942183-80-4 | SCH772984 |
≥98% | | 询价 |
| 11 | 923032-37-5 | Refametinib(RDEA119,BAY86-9766) |
≥98% | | 询价 |
| 12 | 391210-00-7 | PD318088 |
≥98% | | 询价 |
| 13 | 1035555-63-5 | TAK-733 |
≥98% | | 询价 |
| 14 | 869357-68-6 | AZD8330(ARRY704 ARRY424704) |
≥98% | | 询价 |
| 15 | 334949-59-6 | BIX 02188 |
≥98% | | 询价 |
| 16 | 305350-87-2 | SL-327 |
≥98% | | 询价 |
| 17 | 957054-30-7 | GDC-0941(Pictilisib) |
| 5mg, 10mg, 50mg, 200mg | 询价 |
| 18 | 252917-06-9 | CHIR-99021 |
| 2mg, 5mg, 10mg, 50mg, 100mg | 询价 |
| 19 | 1236699-92-5 | Pimasertib(SAR245509,AS703026,MSC1936369B) |
≥98% | | 询价 |
| 20 | 606143-89-9 | Binimetinib(Mektovi ARRY438162 ARRY162 MEK162) |
≥98% | | 询价 |
| 21 | 934660-93-2 | Cobimetinib(GDC-0973,RG-7420,XL-518) |
≥98% | | 询价 |
| 22 | 1168091-68-6 | GDC-0623(G-868) |
≥98% | | 询价 |
| 23 | 1094614-85-3 | BIX 02189 |
≥98% | | 询价 |
| 24 | | NR-160 |
≥98% | | 询价 |
| 25 | 942487-16-3 | PF-03814735 |
≥98% | | 询价 |
| 26 | 945595-80-2 | AMG-900 |
≥98% | | 询价 |
| 27 | 693228-63-6 | CYC116 |
≥98% | | 询价 |
| 28 | 934353-76-1 | ENMD-2076 |
≥98% | | 询价 |
| 29 | 934541-31-8 | TAK-901 |
≥98% | | 询价 |
| 30 | 422513-13-1 | Hesperadin |
≥98% | | 询价 |
| 31 | 398493-79-3 | PHA-680632 |
≥98% | | 询价 |
| 32 | 942947-93-5 | CCT129202 |
≥98% | | 询价 |
| 33 | 1158838-45-9 | TCS7010(Aurora A Inhibitor I) |
≥98% | | 询价 |
| 34 | 1010085-13-8 | MK-5108(VX689) |
≥98% | | 询价 |
| 35 | 5142-23-4 | 3-Methyladenine(3-MA) |
| 25mg, 50mg, 100mg, 200mg, 500mg | 询价 |
| 36 | 1095382-05-0 | CCT137690 |
≥98% | | 询价 |
| 37 | 85622-93-1 | Temozolomide(TMZ) |
| 10mg, 50mg, 100mg, 500mg | 询价 |
| 38 | 616-91-1 | Acetylcysteine(NAC) |
| 500mg | 询价 |
| 39 | 243984-11-4 | TAK-242(Resatorvid) |
| 5mg, 10mg, 25mg | 询价 |
| 40 | 942918-07-2 | GSK1070916(NMI900 or GSK1070916 A) |
≥98% | | 询价 |
| 41 | 15663-27-1 | Cisplatin |
| 100mg, 500mg | 询价 |
| 42 | 443797-96-4 | JNJ-7706621 |
≥98% | | 询价 |
| 43 | 1000669-72-6 | KW-2449 |
≥98% | | 询价 |
| 44 | 885325-71-3 | MK-8745 |
≥98% | | 询价 |
| 45 | 1207293-36-4 | BI-847325 |
≥98% | | 询价 |
| 46 | 827318-97-8 | Danusertib(PHA739358) |
≥98% | | 询价 |
| 47 | 477600-75-2 | Tofacitinib |
| 5mg, 10mg, 50mg, 100mg | 询价 |
| 48 | 869363-13-3 | MLN8054 |
≥98% | | 询价 |
| 49 | 331771-20-1 | ZM 447439 |
≥98% | | 询价 |
| 50 | 722544-51-6 | Barasertib(INH-34 AZD-1152-HQPA) |
≥98% | | 询价 |
| 51 | 639089-54-6 | Tozasertib(VX680 MK0457) |
≥98% | | 询价 |
| 52 | 1028486-01-2 | Alisertib(MLN8237,MLN-8237) |
≥98% | | 询价 |
| 53 | 477600-75-2 | Tofacitinib(CP690550 tasocitinib) |
≥98% | | 询价 |
| 54 | 1229236-86-5 | Gandotinib(LY-2784544) |
≥98% | | 询价 |
| 55 | 1187594-09-7 | Baricitinib(LY-3009104,INCB-028050) |
≥98% | | 询价 |
| 56 | 1146618-41-8 | SNS-314 Mesylate |
≥98% | | 询价 |
| 57 | 1257704-57-6 | CEP-33779 |
≥98% | | 询价 |
| 58 | 4871-97-0 | Curcumol |
≥98% | | 询价 |
| 59 | 937272-79-2 | Pacritinib(SB1518) |
≥98% | | 询价 |
| 60 | 945755-56-6 | XL019 |
≥98% | | 询价 |
m.cnreagent.com